# HOOK (Hookipa Pharma Inc.) - SEC EDGAR Financial Statements

> Hookipa Pharma Inc. reported $9.35M in revenue and a net loss of $73.31M for the trailing twelve months ended March 31, 2025 (down 94.5% year over year), with a -860.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/HOOK
- Markdown: https://convexityos.com/fundamentals/HOOK.md
- SEC CIK: 0001760542
- Reporting currency: USD
- Latest filing period: March 31, 2025
- Last synced: Nov 21, 2026, 05:05 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001760542&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $9.35M | -94.5% YoY |
| Operating Income | TTM | -$80.44M | -860.2% margin |
| Net Income | TTM | -$73.31M | -784.0% net margin |
| Diluted EPS | TTM | -$5.84 | Split-adjusted |
| Free Cash Flow | TTM | -$52.87M | -565.4% FCF margin |
| Cash & ST Investments | Mar 31, 2025 | $40.28M | Total debt: $600K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $43.95M | $20.13M | $14.25M | $18.45M | $19.58M | $11.94M | $7.63M | -- |
| Research & Development | $68.51M | $86.42M | $68.64M | $82.85M | $54.79M | $46.31M | $21.96M | $9.77M |
| **Operating Income** | -$51.45M | -$97.69M | -$73.16M | -$81.67M | -$53.28M | -$51.09M | -$21.18M | -$14.16M |
| **EBITDA** | -$48.70M | -$94.14M | -$69.55M | -$77.03M | -$49.13M | -$48.02M | -$20.54M | -$13.76M |
| Interest Income | $3.70M | $5.29M | $1.63M | $27K | $400K | $1.59M | $0 | -- |
| Interest Expense | $2.0K | $317K | $687K | $898K | $786K | $877K | $778K | $606K |
| Income Before Tax | -$43.61M | -$81.21M | -$64.69M | -$75.66M | -$44.08M | -$43.04M | -$16.21M | -$12.72M |
| Income Tax Expense | -$106K | $368K | $230K | $1.0K | $0 | $0 | $24K | $4.0K |
| **Net Income** | -$43.50M | -$81.58M | -$64.92M | -$75.67M | -$44.08M | -$43.04M | -$16.24M | -$12.72M |
| Basic EPS | -$3.47 | -$8.63 | -$9.91 | -$23.00 | -$16.90 | -$24.10 | -$177.60 | -$139.50 |
| **Diluted EPS** | -$3.47 | -$8.63 | -$9.91 | -$23.00 | -$16.90 | -$24.10 | -$177.60 | -$139.50 |
| Basic Shares Outstanding | 12.5M | 9.5M | 6.6M | 3.3M | 2.6M | 1.8M | 91.4K | 91.2K |
| Diluted Shares Outstanding | 12.5M | 9.5M | 6.6M | 3.3M | 2.6M | 1.8M | 91.4K | 91.2K |

### Income Statement (Quarterly)

| Line Item | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.00M | $1.35M | $4.70M | $1.29M | $36.60M | $7.41M | $6.87M | $2.68M |
| Research & Development | $12.86M | $13.03M | $15.56M | $19.75M | $20.17M | $21.16M | $24.62M | $19.71M |
| **Operating Income** | -$17.87M | -$21.46M | -$18.64M | -$22.46M | $11.11M | -$30.89M | -$22.67M | -$21.47M |
| **EBITDA** | -$17.48M | -$20.76M | -$17.94M | -$21.74M | $11.75M | -$29.62M | -$22.18M | -$20.61M |
| Interest Income | $236K | $488K | $809K | $1.07M | $1.33M | $1.24M | $1.57M | $1.31M |
| Interest Expense | -- | $0 | $0 | $0 | $2.0K | $49K | $49K | $97K |
| Income Before Tax | -$15.43M | -$25.06M | -$13.84M | -$19.09M | $14.38M | -$24.65M | -$19.07M | -$18.02M |
| Income Tax Expense | $0 | -$106K | $0 | $0 | $0 | $164K | $0 | $0 |
| **Net Income** | -$15.43M | -$24.95M | -$13.84M | -$19.09M | $14.38M | -$24.82M | -$19.07M | -$18.02M |
| Basic EPS | -$1.23 | -- | -$1.10 | -$1.52 | $1.15 | -- | -$1.73 | -$2.18 |
| **Diluted EPS** | -$1.23 | -- | -$1.10 | -$1.52 | $1.14 | -- | -$1.73 | -$2.18 |
| Basic Shares Outstanding | 12.5M | -- | 12.5M | 12.5M | 12.5M | -- | 11.0M | 8.3M |
| Diluted Shares Outstanding | 12.5M | -- | 12.5M | 12.5M | 12.6M | -- | 11.0M | 8.3M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $39.68M | $117.1M | $112.5M | $65.92M | $142.7M | $113.2M | $48.58M |
| **Cash & Short-Term Investments** | $39.68M | $117.1M | $112.5M | $65.92M | $142.7M | $113.2M | $48.58M |
| Accounts Receivable, Net | $290K | $511K | $6.53M | $6.89M | $5.54M | $1.54M | $4.92M |
| **Total Current Assets** | $80.67M | $147.1M | $147.2M | $102.1M | $171.5M | $128.0M | $62.31M |
| Property, Plant & Equipment, Net | $179K | $7.74M | $17.97M | $16.35M | $6.22M | $5.13M | $4.34M |
| Other Non-Current Assets | -- | $581K | $863K | $1.37M | $1.91M | $701K | $1.60M |
| **Total Non-Current Assets** | $1.88M | $14.22M | $23.26M | $23.91M | $16.31M | $15.73M | $5.94M |
| **Total Assets** | $82.55M | $161.3M | $170.5M | $126.0M | $187.8M | $143.7M | $68.25M |
| Accounts Payable | $8.69M | $12.50M | $5.49M | $8.76M | $8.01M | $944K | $3.66M |
| Deferred Revenue (Current) | $4.76M | $14.63M | $15.68M | $5.54M | $3.75M | $3.59M | $6.62M |
| **Total Current Liabilities** | $24.65M | $41.99M | $35.63M | $27.65M | $21.14M | $14.76M | $14.70M |
| Long-Term Debt | -- | $1.17M | $2.85M | $6.07M | $6.56M | $7.30M | -- |
| Deferred Revenue (Non-Current) | $725K | $19.67M | $25.66M | $21K | $784K | $72K | $1.66M |
| Other Non-Current Liabilities | $5.63M | $6.02M | $3.42M | $2.65M | $1.41M | $2.23M | $3.10M |
| **Total Non-Current Liabilities** | $6.68M | $29.49M | $32.30M | $8.80M | $10.55M | $11.09M | $9.16M |
| **Total Liabilities** | $31.33M | $71.48M | $67.94M | $36.45M | $31.69M | $25.85M | $23.85M |
| **Total Debt (incl. Leases)** | $900K | $6.57M | $6.86M | $11.77M | $12.86M | $14.90M | -- |
| Common Stock | -- | -- | -- | -- | -- | -- | $0 |
| Retained Earnings | -$412.8M | -$369.3M | -$287.7M | -$222.8M | -$147.1M | -$103.0M | -$59.98M |
| Accumulated Other Comp. Income | -$5.09M | -$7.93M | -$7.16M | -$4.78M | -$6.07M | -$4.65M | -$3.72M |
| **Total Stockholders' Equity** | $51.21M | $89.86M | $102.5M | $89.59M | $156.1M | $117.9M | -$60.38M |
| Total Equity | $51.21M | $89.86M | $102.5M | $89.59M | $156.1M | $117.9M | -$60.38M |

### Balance Sheet (Quarterly)

| Line Item | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $40.28M | $39.68M | $59.75M | $77.15M | $92.75M | $117.1M | $107.7M | $135.6M |
| **Cash & Short-Term Investments** | $40.28M | $39.68M | $59.75M | $77.15M | $92.75M | $117.1M | $107.7M | $135.6M |
| Accounts Receivable, Net | $545K | $290K | $324K | $82K | $10.21M | $511K | $675K | $255K |
| **Total Current Assets** | $60.09M | $80.67M | $93.16M | $107.4M | $132.7M | $147.1M | $139.5M | $168.1M |
| Property, Plant & Equipment, Net | $98K | $179K | $6.86M | $7.01M | $7.33M | $7.74M | $20.17M | $18.22M |
| Other Non-Current Assets | -- | -- | -- | -- | $660K | $581K | $1.09M | $1.00M |
| **Total Non-Current Assets** | $1.17M | $1.88M | $16.57M | $17.70M | $13.16M | $14.22M | $24.54M | $22.97M |
| **Total Assets** | $61.26M | $82.55M | $109.7M | $125.0M | $145.9M | $161.3M | $164.0M | $191.1M |
| Accounts Payable | $3.67M | $8.69M | $8.96M | $11.31M | $11.20M | $12.50M | $8.93M | $11.64M |
| Deferred Revenue (Current) | $3.63M | $4.76M | $5.33M | $4.10M | $4.65M | $14.63M | $16.05M | $19.71M |
| **Total Current Liabilities** | $16.64M | $24.65M | $28.57M | $27.83M | $29.51M | $41.99M | $40.58M | $46.24M |
| Long-Term Debt | -- | -- | -- | -- | $1.14M | $1.17M | $1.12M | $1.16M |
| Deferred Revenue (Non-Current) | $567K | $725K | $1.68M | $1.93M | $2.62M | $19.67M | $23.72M | $27.44M |
| Other Non-Current Liabilities | $9.69M | $5.63M | $6.06M | $5.83M | $5.87M | $6.02M | $3.33M | $3.44M |
| **Total Non-Current Liabilities** | $10.54M | $6.68M | $9.36M | $11.15M | $11.84M | $29.49M | $28.38M | $32.53M |
| **Total Liabilities** | $27.18M | $31.33M | $37.93M | $38.98M | $41.35M | $71.48M | $68.96M | $78.78M |
| **Total Debt (incl. Leases)** | $600K | $900K | $2.80M | $4.90M | $6.14M | $6.57M | $3.92M | $4.46M |
| Retained Earnings | -$428.2M | -$412.8M | -$387.8M | -$374.0M | -$354.9M | -$369.3M | -$344.4M | -$325.4M |
| Accumulated Other Comp. Income | -$6.44M | -$5.09M | -$8.58M | -$7.22M | -$7.40M | -$7.93M | -$6.03M | -$7.24M |
| **Total Stockholders' Equity** | $34.08M | $51.21M | $71.80M | $86.06M | $104.5M | $89.86M | $95.05M | $112.3M |
| Total Equity | $34.08M | $51.21M | $71.80M | $86.06M | $104.5M | $89.86M | $95.05M | $112.3M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$43.50M | -$81.58M | -$64.92M | -$75.67M | -$44.08M | -$43.04M | -$16.24M | -$12.72M |
| Depreciation & Amortization | $2.75M | $3.55M | $3.60M | $4.64M | $4.15M | $3.07M | $640K | $398K |
| Stock-Based Compensation | $2.01M | $2.35M | $5.04M | $7.64M | $8.66M | $5.57M | $867K | $770K |
| Change in Receivables | $524K | $6.18M | -$341K | -$1.94M | -$3.58M | -$3.62M | -$4.99M | -- |
| Change in Payables | -$1.57M | $6.50M | -$2.00M | $858K | $6.30M | $4.20M | $3.41M | -$1.17M |
| **Operating Cash Flow** | -$76.98M | -$57.52M | -$20.00M | -$66.02M | -$39.34M | -$41.73M | -$15.00M | -$11.91M |
| Capital Expenditure | -$194K | -$4.16M | -$5.02M | -$12.58M | -$2.37M | -$2.00M | -$2.15M | -$1.30M |
| **Free Cash Flow** | -$77.17M | -$61.68M | -$25.01M | -$78.60M | -$41.71M | -$43.73M | -$17.15M | -$13.21M |
| **Investing Cash Flow** | -$194K | -$4.16M | -$5.02M | -$12.58M | -$2.37M | -$2.00M | -$2.15M | -$1.30M |
| Common Stock Issued | -- | $49.04M | $45.69M | $203K | $42.64M | $74.76M | $9.0K | -- |
| **Financing Cash Flow** | -$1.28M | $65.67M | $72.27M | -$235K | $73.42M | $109.8M | $6.87M | $58.89M |
| **Net Change in Cash** | -$78.45M | $3.99M | $47.26M | -$78.83M | $31.71M | $66.02M | -$10.28M | $45.68M |

### Cash Flow Statement (Quarterly)

| Line Item | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$15.43M | -$24.95M | -$13.84M | -$19.09M | $14.38M | -$24.82M | -$19.07M | -$18.02M |
| Depreciation & Amortization | $389K | $699K | $700K | $714K | $640K | $1.28M | $487K | $866K |
| Stock-Based Compensation | -$353K | $865K | $939K | $459K | -$249K | $417K | $574K | $696K |
| Change in Receivables | -$231K | -$37K | -$184K | $10.19M | -$9.44M | $342K | -$419K | $118K |
| Change in Payables | -$7.20M | $3.52M | -$3.84M | -$580K | -$669K | $2.40M | -$1.08M | $3.63M |
| **Operating Cash Flow** | $52K | -$20.94M | -$17.51M | -$14.38M | -$24.16M | -$11.22M | -$24.12M | -$19.33M |
| Capital Expenditure | -$20K | -$2.0K | -$31K | -$45K | -$116K | -$422K | -$3.02M | -$445K |
| **Free Cash Flow** | $32K | -$20.94M | -$17.54M | -$14.42M | -$24.27M | -$11.65M | -$27.14M | -$19.78M |
| **Investing Cash Flow** | -$20K | -$2.0K | -$31K | -$45K | -$116K | -$422K | -$3.02M | -$445K |
| Common Stock Issued | -- | -- | -- | -- | -- | $21.25M | -$395K | $28.19M |
| **Financing Cash Flow** | -- | $0 | $0 | -$1.14M | -$135K | $21.25M | -$659K | $45.81M |
| **Net Change in Cash** | $32K | -$20.94M | -$17.54M | -$15.56M | -$24.41M | $9.60M | -$27.80M | $26.04M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -117.1% | -485.3% | -513.4% | -442.7% | -272.1% | -427.8% | -277.6% | -- |
| **Net Profit Margin** | -99.0% | -405.3% | -455.6% | -410.2% | -225.1% | -360.4% | -212.8% | -- |
| Return on Equity (ROE) | -84.9% | -90.8% | -63.3% | -84.5% | -28.2% | -36.5% | -- | -- |
| Return on Assets (ROA) | -52.7% | -50.6% | -38.1% | -60.0% | -23.5% | -29.9% | -23.8% | -- |
| Current Ratio | 3.27x | 3.50x | 4.13x | 3.69x | 8.11x | 8.68x | 4.24x | -- |
| Quick Ratio | 1.62x | 2.80x | 3.34x | 2.63x | 7.01x | 7.77x | 3.64x | -- |
| Debt to Equity | 0.02x | 0.07x | 0.07x | 0.13x | 0.08x | 0.13x | -- | -- |
| **Revenue Growth (YoY)** | +118.3% | +41.3% | -22.8% | -5.8% | +64.0% | +56.5% | -- | -- |
| 5Y Revenue / Share Growth | -47.6% | -97.4% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -860.2% | -117.1% | -121.8% | -124.5% | -119.4% | -485.3% | -391.2% | -494.6% |
| **Net Profit Margin** | -784.0% | -99.0% | -86.7% | -93.2% | -88.7% | -405.3% | -336.1% | -429.1% |
| Return on Equity (ROE) | -215.1% | -84.9% | -60.4% | -56.5% | -45.5% | -90.8% | -72.7% | -60.8% |
| Return on Assets (ROA) | -119.7% | -52.7% | -39.5% | -38.9% | -32.6% | -50.6% | -42.1% | -35.7% |
| Current Ratio | 3.61x | 3.27x | 3.26x | 3.86x | 4.50x | 3.50x | 3.44x | 3.64x |
| Quick Ratio | 2.45x | 1.62x | 2.10x | 2.77x | 3.49x | 2.80x | 2.67x | 2.94x |
| Debt to Equity | 0.02x | 0.02x | 0.04x | 0.06x | 0.06x | 0.07x | 0.04x | 0.04x |
| **Revenue Growth (YoY)** | -94.5% | -81.7% | -31.5% | -51.8% | +1052.4% | -5.4% | +207.9% | -2.4% |
| Operating Income Growth (YoY) | -260.9% | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -207.3% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -207.0% | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -185.4% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -192.9% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
